TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis
Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2014-09, Vol.64 (11), p.B140-B141 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | B141 |
|---|---|
| container_issue | 11 |
| container_start_page | B140 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 64 |
| creator | Sharifi, Mohsen Freeman, Wilbur K Camiliere, Taylor M Vajo, Zoltan Bay, Curt Sharifi, Mirali Schwartz, Frederic |
| description | Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT. |
| doi_str_mv | 10.1016/j.jacc.2014.07.532 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1615797072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109714050724</els_id><sourcerecordid>3470262531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2232-a44101544637d09046b8e24c1b3a12d90bea088d5c224cf178a79b680fe885b53</originalsourceid><addsrcrecordid>eNp9kdGK1DAUhosoOK6-gFcBr1uTNGlSEGEZZ3Vh2F1w1tuQpqdjaicZk3TXeQjfeVNGELzw6hwO_3_y5ztF8ZbgimDSvB-rURtTUUxYhUXFa_qsWBHOZVnzVjwvVljUvCS4FS-LVzGOGONGknZV_N6tdyUTEt3AI7oNekKXLlnj9X6etEsRWYfW2hkI6E4nC8vo3vUQ9t66PbqDYOakHfg5oo3r_QO4pb12CULuk_UODT6grX_MKza_UoCDTSf0CeCIvp3Fu-_BHzofbXxdvBj0FOHNn3pR3F9tdusv5fb28_X6clsaSmtaasbyrzljTS163GLWdBIoM6SrNaF9izvQWMqeZzkzAxFSi7ZrJB5ASt7x-qJ4d957DP7nDDGp0c_B5ScVaQgXrcCCZhU9q0zwMQYY1DHYgw4nRbBasKtRLdjVgl1hoTL2bPpwNkHO_2AhqGgyNgO9DWCS6r39v_3jP3YzWWeNnn7ACeLfmCpShdXX5a7LWQnDPGdm9RNVVaDq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1615797072</pqid></control><display><type>article</type><title>TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis</title><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Sharifi, Mohsen ; Freeman, Wilbur K ; Camiliere, Taylor M ; Vajo, Zoltan ; Bay, Curt ; Sharifi, Mirali ; Schwartz, Frederic</creator><creatorcontrib>Sharifi, Mohsen ; Freeman, Wilbur K ; Camiliere, Taylor M ; Vajo, Zoltan ; Bay, Curt ; Sharifi, Mirali ; Schwartz, Frederic</creatorcontrib><description>Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2014.07.532</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Anticoagulants ; Cancer ; Cardiology ; Cardiovascular ; Drug therapy ; Internal Medicine ; Mortality ; Patient satisfaction ; Thrombosis</subject><ispartof>Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.B140-B141</ispartof><rights>2014</rights><rights>Copyright Elsevier Limited Sep 16, 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2014.07.532$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids></links><search><creatorcontrib>Sharifi, Mohsen</creatorcontrib><creatorcontrib>Freeman, Wilbur K</creatorcontrib><creatorcontrib>Camiliere, Taylor M</creatorcontrib><creatorcontrib>Vajo, Zoltan</creatorcontrib><creatorcontrib>Bay, Curt</creatorcontrib><creatorcontrib>Sharifi, Mirali</creatorcontrib><creatorcontrib>Schwartz, Frederic</creatorcontrib><title>TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis</title><title>Journal of the American College of Cardiology</title><description>Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.</description><subject>Anticoagulants</subject><subject>Cancer</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Internal Medicine</subject><subject>Mortality</subject><subject>Patient satisfaction</subject><subject>Thrombosis</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kdGK1DAUhosoOK6-gFcBr1uTNGlSEGEZZ3Vh2F1w1tuQpqdjaicZk3TXeQjfeVNGELzw6hwO_3_y5ztF8ZbgimDSvB-rURtTUUxYhUXFa_qsWBHOZVnzVjwvVljUvCS4FS-LVzGOGONGknZV_N6tdyUTEt3AI7oNekKXLlnj9X6etEsRWYfW2hkI6E4nC8vo3vUQ9t66PbqDYOakHfg5oo3r_QO4pb12CULuk_UODT6grX_MKza_UoCDTSf0CeCIvp3Fu-_BHzofbXxdvBj0FOHNn3pR3F9tdusv5fb28_X6clsaSmtaasbyrzljTS163GLWdBIoM6SrNaF9izvQWMqeZzkzAxFSi7ZrJB5ASt7x-qJ4d957DP7nDDGp0c_B5ScVaQgXrcCCZhU9q0zwMQYY1DHYgw4nRbBasKtRLdjVgl1hoTL2bPpwNkHO_2AhqGgyNgO9DWCS6r39v_3jP3YzWWeNnn7ACeLfmCpShdXX5a7LWQnDPGdm9RNVVaDq</recordid><startdate>20140916</startdate><enddate>20140916</enddate><creator>Sharifi, Mohsen</creator><creator>Freeman, Wilbur K</creator><creator>Camiliere, Taylor M</creator><creator>Vajo, Zoltan</creator><creator>Bay, Curt</creator><creator>Sharifi, Mirali</creator><creator>Schwartz, Frederic</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20140916</creationdate><title>TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis</title><author>Sharifi, Mohsen ; Freeman, Wilbur K ; Camiliere, Taylor M ; Vajo, Zoltan ; Bay, Curt ; Sharifi, Mirali ; Schwartz, Frederic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2232-a44101544637d09046b8e24c1b3a12d90bea088d5c224cf178a79b680fe885b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anticoagulants</topic><topic>Cancer</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Internal Medicine</topic><topic>Mortality</topic><topic>Patient satisfaction</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharifi, Mohsen</creatorcontrib><creatorcontrib>Freeman, Wilbur K</creatorcontrib><creatorcontrib>Camiliere, Taylor M</creatorcontrib><creatorcontrib>Vajo, Zoltan</creatorcontrib><creatorcontrib>Bay, Curt</creatorcontrib><creatorcontrib>Sharifi, Mirali</creatorcontrib><creatorcontrib>Schwartz, Frederic</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharifi, Mohsen</au><au>Freeman, Wilbur K</au><au>Camiliere, Taylor M</au><au>Vajo, Zoltan</au><au>Bay, Curt</au><au>Sharifi, Mirali</au><au>Schwartz, Frederic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2014-09-16</date><risdate>2014</risdate><volume>64</volume><issue>11</issue><spage>B140</spage><epage>B141</epage><pages>B140-B141</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2014.07.532</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.B140-B141 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1615797072 |
| source | Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Anticoagulants Cancer Cardiology Cardiovascular Drug therapy Internal Medicine Mortality Patient satisfaction Thrombosis |
| title | TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T19%3A43%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCT-478%20New%20Oral%20Anticoagulants%20in%20Cancer%20Patients%20Undergoing%20Percutaneous%20Endovenous%20Intervention%20for%20Lower%20Extremity%20Deep%20Venous%20Thrombosis&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Sharifi,%20Mohsen&rft.date=2014-09-16&rft.volume=64&rft.issue=11&rft.spage=B140&rft.epage=B141&rft.pages=B140-B141&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2014.07.532&rft_dat=%3Cproquest_cross%3E3470262531%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1615797072&rft_id=info:pmid/&rft_els_id=S0735109714050724&rfr_iscdi=true |